Nodular Regenerative Hyperplasia Induced by Trastuzumab Emtansine: Role of Emtansine?

by Marion Lepelley, Marion Allouchery, Jérôme Long, Dorothée Boucherle, Yves Ranchoup, François Le Marc’Hadour, Céline Villier, Nathalie Sturm
Published 2018-11-01

Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer

by Mickaël Martin, Marion Sassier, Marion Allouchery, Thomas Lombard, Franck Rouby, Celia Bertin, Marina Atzenhoffer, Ghada Miremont-Salame, Marie-Christine Perault-Pochat, Mathieu Puyade
Published 2020-07-01